Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-475 as add-on to statins in hypercholesterolemia
NCT00532311Phase 3Terminated
- Sponsor
- Takeda
- Start
- Jul 2007
- Primary completion
- Apr 2008
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lapaquistat in hypercholesterolemia and hypertriglyceridemia, sponsored by Takeda. Started Jul 2007; status: terminated.
02
Drugs
lapaquistat
03
Conditions
hypercholesterolemiahypertriglyceridemia
Beyond the preview
Go deeper on NCT00532311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00532311.